Viewing StudyNCT06262438



Ignite Creation Date: 2024-05-06 @ 8:08 PM
Last Modification Date: 2024-10-26 @ 3:21 PM
Study NCT ID: NCT06262438
Status: RECRUITING
Last Update Posted: 2024-02-16
First Post: 2024-01-26

Brief Title: CHIP-AML22Quizartinib Quizartinib Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD and NPM1wt AML Patients
Sponsor: Princess Maxima Center for Pediatric Oncology
Organization: Princess Maxima Center for Pediatric Oncology

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia in Children
Keywords:
Name View
FLT3-ITD NPM1wt AML View